starpharma | home
home
about starpharma
technology
product pipeline
news room
investor relations
careers contact us
site search

Intellectual Property
 
  Selected Patents

Starpharma holds a central position in the dendrimer IP landscape with a wide portfolio of patents and patent applications covering both the composition and application of dendrimers in pharmaceutical and life-science fields.

Starpharma has over:

  • 11 active patent families
  • 38 issued patents
  • 44 pending applications

Key Areas of Patent Protection

Dendrimers as Drugs - VivaGel®

 

Dendrimers for Drug Delivery/Modification

Composition of Matter

STI Prevention (HIV, Genital Herpes, Human Papillomavirus, Chlamydia)

Inhibition of microbial or parasitic agents
Condom Coating

Contraception

Hyaluronidase Inhibition

 

Dendrimers with controlled topography

Dendrimers with a unique point of attachment

Dendrimers for ADME engineering

Dendrimers for targeted delivery of imaging agents

Starpharma also has additional patents and patent applications in areas such as therapeutics, drug delivery and modification, dyes and water remediation.

For more information on IP, please contact us.